Hard To Treat Diseases (HTDS) Chile flu vaccine tender

Hard to Treat Diseases, Inc. subsidiary, Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope) announced today that the general manager of Mellow Hope paid a visit to Chile, in regards to a significant new business development opportunity related to Mellow Hope's MedVac flu vaccine products. The company intends to participate in a formal tender process to supply a couple separate orders to a couple separate and unrelated entities in Chile.

The company is pleased to report that the company has made a significant progress to secure these couple of interests in Chile. Mellow Hope is tendering between 2,000,000 to 5,000,000 doses of Flu vaccine, for the Chilean market.

Mr. Eric Yuan, Spokesperson for the company, said, "The reason this announcement is being made is three fold. Firstly, to keep our followers and shareholders advised of our daily and ongoing business activities. Secondly certain Mellow Hope filings with the Chilean authorities in regards to the tender process will be made public shortly. Although available in Spanish only, the Company felt that shareholders should be advised directly, in order to avoid any distortions or rumors should news of these filings leak out through other channels. Finally, should the bid submission be successful, this may very well be the largest single order the company will fulfill to date, and would represent a material business development of interest to our shareholders."

In order to highlight our excitement and expectations Mellow Hope's usual tender is in the 250,000 doses of Flu vaccine range such as our recent announcement July 15, 2009, Indonesia transaction. and our July 10th 2009 India news release http://www.htdsmedical.com

Again, as this is worth repeating Mellow Hope is tendering between 2,000,000 to 5,000,000 doses of Flu vaccine, for the Chilean market.

Mellow Hope product specifications and details can be viewed by visiting our web page directly

This is an important update to our followers. The company will release further updates as they become available, and will refer back to this news release periodically to avoid any confusion, due to the fact that there are multiple pending tenders in Chile.